California-based biopharma BridgeBio Pharma (Nasdaq: BBIO) has announced the completion of a $200 million private financing of its former subsidiary, TheRas. 3 May 2024
Amgen has reported better-than-expected first quarter results, with simultaneous news from its obesity pipeline lifting the firm’s stock price by over a tenth. 3 May 2024
Positive data for Enhertu (trastuzumab deruxtecan), an antibody-drug conjugate (ADC), have been revealed from the Phase III DESTINY-Breast06 study. 29 April 2024
Osaka-based drugmaker Ono Pharmaceutical has entered into a drug discovery collaboration agreement with fellow Japanese firm PRISM BioLab. 29 April 2024
A commercial stage biopharmaceutical R&D company, focused on the development of products that address the medical challenges in the therapeutic area of anti-infectives.